These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37311279)

  • 1. β-Cyclodextrins as affordable antivirals to treat coronavirus infection.
    Raïch-Regué D; Tenorio R; Fernández de Castro I; Tarrés-Freixas F; Sachse M; Perez-Zsolt D; Muñoz-Basagoiti J; Fernández-Sánchez SY; Gallemí M; Ortega-González P; Fernández-Oliva A; Gabaldón JA; Nuñez-Delicado E; Casas J; Roca N; Cantero G; Pérez M; Usai C; Lorca-Oró C; Alert JV; Segalés J; Carrillo J; Blanco J; Clotet Sala B; Cerón-Carrasco JP; Izquierdo-Useros N; Risco C
    Biomed Pharmacother; 2023 Aug; 164():114997. PubMed ID: 37311279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections: A Preclinical Study.
    Lu A; Ebright B; Naik A; Tan HL; Cohen NA; Bouteiller JC; Lazzi G; Louie SG; Humayun MS; Asante I
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytopathic Effect Assay and Plaque Assay to Evaluate
    Hu Y; Ma C; Wang J
    Bio Protoc; 2022 Feb; 12(3):e4314. PubMed ID: 35284599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing activity of Usnic acid and β-cyclodextrins complex against SARS-CoV-2 spike pseudovirus.
    Rosa L; Cutone A; Galla R; Uberti F; Valenti P
    Nat Prod Res; 2024 Jun; 38(12):2129-2134. PubMed ID: 37436919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antiviral activity of two structurally analogous CYP3A inhibitors against pathogenic human coronaviruses in vitro.
    Gallucci L; Bazire J; Davidson AD; Shytaj IL
    Antiviral Res; 2024 Jan; 221():105766. PubMed ID: 38042417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
    Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M
    Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease M
    Biolatti M; Blangetti M; Baggieri M; Marchi A; Gioacchini S; Bajetto G; Arnodo D; Bucci P; Fioravanti R; Kojouri M; Bersani M; D'Arrigo G; Siragusa L; Ghinato S; De Andrea M; Gugliesi F; Albano C; Pasquero S; Visentin I; D'Ugo E; Esposito F; Malune P; Tramontano E; Prandi C; Spyrakis F; Magurano F; Dell'Oste V
    ACS Infect Dis; 2023 Jul; 9(7):1310-1318. PubMed ID: 37358826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro.
    Andreu S; Ripa I; Bello-Morales R; López-Guerrero JA
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lichen or Associated Micro-Organism Compounds Are Active against Human Coronaviruses.
    Desmarets L; Millot M; Chollet-Krugler M; Boustie J; Camuzet C; François N; Rouillé Y; Belouzard S; Tomasi S; Mambu L; Séron K
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.
    Wang R; Zhai G; Zhu G; Wang M; Gong X; Zhang W; Ge G; Chen H; Chen L
    Bioorg Chem; 2023 Jan; 130():106264. PubMed ID: 36395603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals.
    de León P; Cañas-Arranz R; Bustos MJ; Sáiz M; Sobrino F
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0170322. PubMed ID: 36975844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.
    Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin from
    Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.